PPlanet Innovation provides end-to-end healthtech product development and commercialization services, covering market opportunity assessment, design and engineering, digital solutions, manufacturing, and go-to-market launch. Its process takes a product from identifying a market need through to scalable manufacturing and a commercial launch, usually via project-based work or long-term partnerships. The company distinguishes itself with an integrated, full-spectrum service model and expanded medtech manufacturing capacity, including the BIT acquisition that doubled its North American operations. Its goal is to help healthtech innovations reach customers efficiently and achieve sustainable commercial success.
Work here?Claim your company
Industries
Company Size
201-500
Company Stage
Late Stage VC
Total Funding
$13M
Headquarters
Melbourne VIC, Australia
Founded
2009
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$13M
Above
Industry Average
Funded Over
3 Rounds
Herbert Smith Freehills Kramer advises Meiban Group on the acquisition of Planet Innovation. * Author Cynthia Lydia Marbaniang * Published November 10, 2026 Herbert Smith Freehills Kramer (HSF Kramer) has advised Meiban Group (Meiban) on its acquisition of Planet Innovation by way of scheme of arrangement. Meiban is a global contract development and manufacturing organisation offering a comprehensive range of product development and advanced manufacturing capabilities. Meiban has global operations throughout Asia, the United States, Europe and Australia with facilities across Singapore and Malaysia, specialising in high-volume, precision manufacturing for the medtech sector. Founded in Melbourne, Planet Innovation is a medtech product development company, partnering with medtech companies globally to design, develop and manufacture regulated medical devices in its facilities in Australia and the United States. The transaction follows a strategic alliance announced by the companies in 2025, where Meiban acquired an initial ~19.9% stake in Planet Innovation. The transaction will enable the two parties to combine their complementary businesses into an integrated contract development and manufacturing organisation serving the global medtech sector. The HSF Kramer team was led by partner Jason Jordan and senior associate Damien Devnarain, with support from solicitors Sandra Nguyen and Rosalind Wei. Jason said, "It was a pleasure to work with the Meiban team on this transaction, supporting its entry into the Australian market and its broader vision to improve lives through the products both organisations help bring to market." This transaction is another example of HSF Kramer's market-leading work in M&A. Other recent examples include advising: Where the legal industry reads first. No spam. Unsubscribe anytime. From Legal Desire Is your firm the one being cited, or the one being skipped? Legal Desire ran the test. On several everyday legal questions, software companies are answering and law firms are not. Legal Desire help firms fix that, and Legal Desire build the technology behind the practice. Lawyers and firms: get featured on Legal Desire. Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC. See the full deal record on DealDatabase The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
Herbert Smith Freehills Kramer (HSF Kramer) has advised Meiban Group on its acquisition of Planet Innovation by way of a scheme of arrangement. No deal value was disclosed. Meiban is a global contract development and manufacturing organisation with facilities in Singapore and Malaysia, specialising in high-volume, precision manufacturing for the medtech sector. Planet Innovation, founded in Melbourne, designs, develops and manufactures regulated medical devices in Australia and the United States. The deal follows a 2025 strategic alliance in which Meiban bought an initial stake of about 19.9% in Planet Innovation. The two businesses will combine into an integrated contract development and manufacturing organisation serving the global medtech sector. Partner Jason Jordan and senior associate Damien Devnarain led the HSF Kramer team. Jordan said the deal supports Meiban's entry into the Australian market.
Dymon has been looking to sell its stake in Meiban.
Quantum-Si also partnered with Planet Innovation to develop and manufacture Proteus.
Patrick will build a sales team composed of direct representatives and channel partners, enabling our system to provide enhanced patient care in the field of oncology. -- ASP Health EVP and CCO Hari Subramanian, PhD, MBA
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
201-500
Company Stage
Late Stage VC
Total Funding
$13M
Headquarters
Melbourne VIC, Australia
Founded
2009
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs